Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5700888 | European Journal of Surgical Oncology (EJSO) | 2017 | 7 Pages |
Abstract
Preoperative mGPS may be a cost effective prognostic tool for predicting OS and DFS in patients following complete CRS-HIPEC, and performs well compared to TM for predicting patients at high risk of recurrence.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
G.H.C. Tan, C.A. Novo, S. Dayal, K. Chandrakumaran, F. Mohamed, T. Cecil, B.J. Moran,